 |
Ulrik Vejlsgaard
Chief Financial Officer
Prior to joining 7TM Pharma, Ulrik Vejlsgaard held a similar position in BioImage (now ThermoFischer), where he was instrumental in closing two major financing rounds as well as orchestrating BioImage’s efficient and lucrative licensing programs, which include license deals with Eli Lilly and Merck.
Before co-founding and joining BioImage, Ulrik Vejlsgaard was employed at Novo Nordisk in different managerial positions in finance and corporate development. Earlier in his career he worked in investment banking and as accountant in Salomon Brothers and PriceWaterhouse. He is also a board member of LiNA Medical; a company developing and selling surgical equipment. Ulrik Vejlsgaard holds a MSc (Econ) from Copenhagen Business School and a MBA from London Business School.